Quarterly report pursuant to sections 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended 165 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Net sales         $ 69,000
Cost of goods sold         24,120
Gross profit         44,880
Operating expenses 2,129,273 389,519 4,640,508 3,011,488 41,898,462
Research and development expenses 379,391 140,486 931,959 344,581 7,246,673
Non-cash patent settlement costs         1,610,066
Loss before other income (expense) (2,508,664) (530,005) (5,572,467) (3,356,069) (50,710,321)
Other income 112,453   150,903 5,196 294,875
Interest income         16,342
Interest and financing expense (1,014,043) (461,047) (4,810,735) (3,235,068) (16,403,099)
Change in fair value of derivative liabilities 1,158,500 29,716 2,722,084 1,300,845 2,828,749
Costs of private placement       (1,129,212) (1,640,715)
Costs to induce conversion of notes       (168,340) (469,043)
Loss on disposition of equipment         (14,426)
Settlement of Debt Due Morale/Matthews         (927,903)
Settlement of litigation and debt         1,089,088
Loss before provision for income taxes (2,251,754) (961,336) (7,510,215) (6,582,648) (65,936,453)
Provision for income taxes     800 800 7,482
Net loss $ (2,251,754) $ (961,336) $ (7,511,015) $ (6,583,448) $ (65,943,935)
Net loss per share, basic and diluted (in Dollars per share) $ (0.02) $ (0.01) $ (0.07) $ (0.08)  
Weighted average common shares outstanding, basic and diluted (in Shares) 109,394,365 85,033,769 100,944,733 80,211,124